EUVIMEDEUVIMED entdecken
Crossref

Cardiac amyloidosis and implantable cardioverter‑defibrillator implantation — should threshold criteria be reconsidered in the absence of classical indications?

Raman Zhdanovich, Aleksey Goshev, Uladzislau Shyshko, Volga Vrubleuskaya

Medical Research Journal · 15.01.2026 · 11

DOI: 10.5603/mrj.110313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Research Journal, online erschienen am 15.01.2026. Verfasst von Raman Zhdanovich und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhdanovich, R., Goshev, A., Shyshko, U., & Vrubleuskaya, V. (2026). Cardiac amyloidosis and implantable cardioverter‑defibrillator implantation — should threshold criteria be reconsidered in the absence of classical indications?. Medical Research Journal, 11(0). https://doi.org/10.5603/mrj.110313

Vancouver

Zhdanovich R, Goshev A, Shyshko U, Vrubleuskaya V. Cardiac amyloidosis and implantable cardioverter‑defibrillator implantation — should threshold criteria be reconsidered in the absence of classical indications?. Medical Research Journal. 2026;11(0). doi:10.5603/mrj.110313

BibTeX
@article{Zhdanovich2026,
  author = {Zhdanovich, Raman and Goshev, Aleksey and Shyshko, Uladzislau and Vrubleuskaya, Volga},
  title = {Cardiac amyloidosis and implantable cardioverter‑defibrillator implantation — should threshold criteria be reconsidered in the absence of classical indications?},
  journal = {Medical Research Journal},
  year = {2026},
  volume = {11},
  number = {0},
  doi = {10.5603/mrj.110313}
}
Kostenlos starten →